Market Tracker

02/20 5:33am ET

Impax Laboratories Inc (NASDAQ:IPXL)

14.60
Delayed Data
As of Feb 17
 0.00 / 0.00%
Today’s Change
11.65
Today|||52-Week Range
37.20
+10.19%
Year-to-Date

Today’s Trading

Previous close14.60
Today’s open14.55
Day’s range14.35 - 14.70
Volume378,336
Average volume (3 months)1,317,915
Market cap$1.1B
Dividend yield--
Data as of 4:00pm ET, 02/17/2017

Growth & Valuation

Earnings growth (last year)-33.33%
Earnings growth (this year)-19.58%
Earnings growth (next 5 years)+5.00%
Revenue growth (last year)+44.36%
P/E ratioNM
Price/Sales3.58
Price/Book1.00

Competitors

 Today’s
change
Today’s
% change
LOXOLoxo Oncology Inc+0.36+0.87%
SGYPSynergy Pharmaceutic...+0.01+0.17%
TXMDTherapeuticsMD Inc-0.15-2.60%
RGENRepligen Corp+0.13+0.42%
Data as of 4:00pm ET, 02/17/2017

Financials

Next reporting dateMarch 1, 2017
EPS forecast (this quarter)$0.15
Annual revenue (last year)$860.5M
Annual profit (last year)$39.0M
Net profit margin4.53%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
J. Kevin Buchi
Senior Vice President-
Global Operations
Andrew Schaschl
Corporate headquarters
Hayward, California

Forecasts